A defining characteristic for both HL and ALCL is the presence of a common surface molecule, CD30, a transmembrane receptor and member of the tumor necrosis factor (TNF) receptor superfamily [10, 11]. This evidence concerns the gene TNFRSF8 and Hodgkins lymphoma.